OCM
Objective Capital Management’s Edwards Lifesciences EW Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $783K | Buy |
10,012
+37
| +0.4% | +$2.89K | 0.88% | 31 |
|
|
2025
Q1 | $723K | Sell |
9,975
-100
| -1% | -$7.25K | 0.92% | 30 |
|
|
2024
Q4 | $746K | Sell |
10,075
-35
| -0.3% | -$2.59K | 0.5% | 48 |
|
|
2024
Q3 | $667K | Buy |
+10,110
| New | +$667K | 0.39% | 59 |
|
|
2024
Q1 | $979K | Buy |
10,245
+10
| +0.1% | +$956 | 0.66% | 39 |
|
|
2023
Q4 | $780K | Buy |
10,235
+10
| +0.1% | +$763 | 0.59% | 40 |
|
|
2023
Q3 | $708K | Sell |
10,225
-72
| -0.7% | -$4.99K | 0.63% | 39 |
|
|
2023
Q2 | $971K | Hold |
10,297
| – | – | 0.85% | 36 |
|
|
2023
Q1 | $852K | Hold |
10,297
| – | – | 0.78% | 36 |
|
|
2022
Q4 | $768K | Hold |
10,297
| – | – | 0.76% | 37 |
|
|
2022
Q3 | $851K | Hold |
10,297
| – | – | 0.91% | 34 |
|
|
2022
Q2 | $979K | Sell |
10,297
-75
| -0.7% | -$7.13K | 0.99% | 31 |
|
|
2022
Q1 | $1.22M | Hold |
10,372
| – | – | 0.94% | 28 |
|
|
2021
Q4 | $1.34M | Buy |
+10,372
| New | +$1.34M | 0.95% | 27 |
|